Divestment

Shell plc publishes first quarter 2023 press release

Retrieved on: 
星期四, 五月 4, 2023
Carbon, Shell, Shell plc, Net, Bank statement, Coronavirus, Act, COVID-19, Disclosure, GAAP, Arrangement, Risk, Movement, Registrar, Pandemic, EBITDA, Climate change, Divestment, Acquisition, Developed country, Annual report, Nationalization, Natural gas, NCI, Companies Act 2006, Bank, Audit

The companies in which Shell plc directly and indirectly owns investments are separate legal entities.

Key Points: 
  • The companies in which Shell plc directly and indirectly owns investments are separate legal entities.
  • In this announcement "Shell", "Shell Group" and "Group" are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • Likewise, the words "we", "us" and "our" are also used to refer to Shell plc and its subsidiaries in general or to those who work for them.
  • "Subsidiaries", "Shell subsidiaries" and "Shell companies" as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.

LithiumBank Appoints Strategy and M&A Executive Formerly at Shell, Citigroup and McKinsey Ekaterina Zotova as New Director and Announces AGM Results

Retrieved on: 
星期一, 五月 1, 2023
Real, Shell, Shell plc, Antler, Private equity, Marketing, World Energy Council, Vedanta Resources, Senior advisor, L1 Energy, Corporation, Divestment, Meeting, USD, McKinsey & Company, Lithium, Energy transition, Harland, Citigroup, Special, TSX, Growth, Knowledge, Proxy, Mizuho Financial Group, Security (finance), Holding company, Shareholder, Western Canada

Ms. Zotova spent 25 years in strategy and corporate finance, private equity and investment banking across Europe, Middle East, Africa, Asia and the Americas.

Key Points: 
  • Ms. Zotova spent 25 years in strategy and corporate finance, private equity and investment banking across Europe, Middle East, Africa, Asia and the Americas.
  • Ms. Zotova is currently an Advisor on Energy Transition, Infrastructure and Industrials at Antler VC Fund and a non executive director for Harland & Wolff plc.
  • During the course of her career, Ms. Zotova lived and worked in the Netherlands, USA, UK, UAE, South Africa and Russia.
  • To the knowledge of the Company, Real Creative and Scott Shaffer do not own any common shares or warrants of LithiumBank.

Borqs Technologies Letter to Shareholders Regarding the Divestment of Solar Subsidiary

Retrieved on: 
星期三, 四月 26, 2023
Internet of things, Committee, Trust, SolarCity, Sale, Military personnel, Government, Chairperson, Tesla, Inc., Divestment, HHE, CFIUS, Acquisition, Artificial intelligence, Growth, Foreign investment, Letter, Committee on Foreign Investment in the United States, Holding company, Cryptocurrency, Borqs

Dear Shareholders of Borqs Technologies, Inc.:

Key Points: 
  • Dear Shareholders of Borqs Technologies, Inc.:
    The purpose of this letter is to help clarify the proposed divestment of our company’s ownership in Holu Hou Energy, LLC (“HHE”) and the implications that this transaction may have to Borqs and our shareholders.
  • CFIUS therefore required Borqs and HHE to enter into a National Security Agreement with CFIUS, pursuant to which Borqs must divest its interests in HHE.
  • The Management at Borqs is committed to sustainable growth of the Company and creating shareholder value in the long term.
  • We have seen Borqs as a global company at the very beginning and will continue to expand our businesses internationally.

30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications

Retrieved on: 
星期三, 四月 19, 2023
Infection, COPD, Social work, LSE, Research and development, Therapy, Powder, CTEC, Stifel, Respiratory disease, Nitric oxide, Health, Immunity, Research, Cystic fibrosis, National Institute of General Medical Sciences, IP, Fungus, Sale, CN v Secretary of State for Health and Social Care, Divestment, NO, Patent, Patient, Ophthalmology, Convatec, Bacteria, NHS, Burns, Rare, Scottish Enterprise, Virus, Dentistry, Pharmaceutical industry, Vaccine, Bronchiectasis

London, UK, 19 April 2023 – 30 Technology, the world leader in clinical nitric oxide generation technology for health care, today announced that it has completed the sale of its antimicrobial nitric oxide platform in certain applications to Convatec Group Plc (LSE: CTEC).

Key Points: 
  • London, UK, 19 April 2023 – 30 Technology, the world leader in clinical nitric oxide generation technology for health care, today announced that it has completed the sale of its antimicrobial nitric oxide platform in certain applications to Convatec Group Plc (LSE: CTEC).
  • As part of the transaction, a small team from 30 Technology will transfer across to Convatec.
  • Syd Hanna, Group Executive Director of 30 Technology commented: “This transaction validates 30 Technology’s transformational approach to unlock the potential of nitric oxide to treat a range of infections with a durable and safe treatment.
  • Stifel acted as financial advisor and Goodwin Procter provided legal counsel to 30 Technology.

GEHI Announces Acquisition of eLMTree and Divestiture of its PRC Business

Retrieved on: 
星期二, 四月 18, 2023
Online, Slate, Communication, Cayman, Okapi BM25, NetDragon Websoft, Tripura Merger Agreement, K-12, Acquisition, Report of the Special Committee on the Termination of the National Emergency, ND, NYSE, Transaction document, Transaction, Skadden, Arps, Slate, Meagher & Flom, Effectiveness, Growth, Douglas F3D Skyknight, Virgin Islands, Parent, Committee, Ministry, HKEX, SPA, ACP, Equity value, British Virgin Islands, Education, School, Student, Security (finance), PRC, Divestment, Edmodo, Closing, Sale, Promethean, Mergers and acquisitions

It's contemplated that Best Assistant will form a Cayman Islands exempted company limited by shares ("eLMTree") as its wholly owned subsidiary and transfer the education business of NetDragon outside of the PRC to eLMTree.

Key Points: 
  • It's contemplated that Best Assistant will form a Cayman Islands exempted company limited by shares ("eLMTree") as its wholly owned subsidiary and transfer the education business of NetDragon outside of the PRC to eLMTree.
  • Pursuant to Divestiture Agreement, immediately prior to the Closing, the Company will transfer all its education business in China to the Divestiture Purchaser (the "Divestiture") at a consideration of US$15 million (the "Divestiture Consideration").
  • Upon completion of the Divestiture, the Company will cease to operate any education business in China.
  • eLMTree is expected to comprise the non-PRC education business operated by NetDragon, including through the following subsidiaries (i) Promethean World Limited ("Promethean"); (ii) Edmodo, LLC.

THE LAWFARE PROJECT FILES LAWSUIT TO CANCEL MAYOR OF BARCELONA'S ANTI-ISRAEL BOYCOTT

Retrieved on: 
星期一, 四月 17, 2023
Apartheid, Lawfare, BDS, Speech, Policy, Hope, Movement, Boycott, Divestment, Lawfare Project, City, BNC, Drug

NEW YORK, April 17, 2023 /PRNewswire/ -- The Lawfare Project (LP) announced today that it filed a lawsuit (registration # 2786/2023) against the Mayor of Barcelona, Ms. Ada Colau, challenging her February 8, 2023 suspension of relations with Israel and all its institutions, including the international agreement of cooperation and friendship signed with the city of Tel Aviv. The lawsuit was filed on behalf of the Barcelona Institute for Dialogue with Israel With Israel, a local charity. It asserts that Ms. Colau acted beyond the scope of her authority by infringing on the Spanish government's power to conduct foreign policy and violated applicable legal procedures. 

Key Points: 
  • The lawsuit was filed on behalf of the Barcelona Institute for Dialogue with Israel With Israel, a local charity.
  • It asserts that Ms. Colau acted beyond the scope of her authority by infringing on the Spanish government's power to conduct foreign policy and violated applicable legal procedures.
  • Ms. Colau justified the boycott of Israel based on alleged "systematic violation of human rights."
  • She closed her speech to the press by expressing her hope that mayors of other cities would join her action and repeated the slogan of the boycott campaign, "Barcelona says no to apartheid."

AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals

Retrieved on: 
星期二, 三月 14, 2023
Education, Pain, Pain management, Emergency Use Authorization, Ephedrine, Medication, U.S. Department of Defense Strategy for Operating in Cyberspace, United States Department of Defense, Hospital, EUA, Patient, Divestment, Growth, NDA, FDA, Employment, Department of Defence, Music, Pharmaceutical industry, Nursing, Alora

HAYWARD, Calif., March 14, 2023 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the divestment of its FDA-approved drug, DSUVIA® to Alora Pharmaceuticals (Alora).  The agreement allows AcelRx to participate in the long-term value expected to be created by Alora as they expand the commercialization of DSUVIA. 

Key Points: 
  • The agreement allows AcelRx to participate in the long-term value expected to be created by Alora as they expand the commercialization of DSUVIA.
  • Closing of the transaction is expected by the end of the month, and AcelRx will provide, and be reimbursed for, transition services during a period of up to 6 months post-closing.
  • "We are proud to partner with AcelRx to continue the growth and distribution of DSUVIA to ensure access by patients.
  • This product will help Alora Pharmaceuticals expand our pain management portfolio.

Light & Wonder, Inc. Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
星期三, 三月 1, 2023
Entertainment, Technology, Mobile Entertainment, Software, Electronic Games, Hardware, Casino, Gaming, Sale, Light & Wonder, Tax, AEBITDA, Igam Ogam, Growth, Bank, Video game, Cryptocurrency, VAT, Divestment

Fourth Quarter 2022 Financial Highlights:

Key Points: 
  • Fourth Quarter 2022 Financial Highlights:
    Fourth quarter consolidated revenue was $682 million compared to $580 million, an 18% increase relative to the prior year period driven by double-digit growth across all lines of business, with Gaming maintaining strong momentum.
  • Full Year 2022 Financial Highlights:
    Consolidated revenue was $2,512 million compared to $2,153 million, a 17% increase relative to the prior year.
  • We paid down approximately $4.8 billion of debt during 2022, reducing debt outstanding by 55% to $3.9 billion at the end of 2022.
  • Foreign currency impact on iGaming revenue for the fourth quarter of 2022 was $4 million.

Shell Plc publishes fourth quarter 2022 press release

Retrieved on: 
星期四, 二月 2, 2023
Carbon, GAAP, Pandemic, Divestment, The Act, COVID-19, Coronavirus, Acquisition, Shell, Risk, Investment Company Act of 1940, Disease, Registrar, EBITDA, NCF, Disclosure, Movement, Nationalization, Net, Natural gas, Climate change, Annual report, Bank, Security (finance)

The companies in which Shell plc directly and indirectly owns investments are separate legal entities.

Key Points: 
  • The companies in which Shell plc directly and indirectly owns investments are separate legal entities.
  • In this announcement “Shell”, “Shell Group” and “Group” are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general.
  • “Subsidiaries”, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Shell plc either directly or indirectly has control.
  • The information in this announcement does not constitute the unaudited condensed consolidated financial statements which are contained in Shell’s fourth quarter 2022 unaudited results available on www.shell.com/investors.

WISeKey Announces FY 2022 Preliminary Revenues of $25.6 Million, a 15% Increase from FY 2021, Despite the Divestiture of arago

Retrieved on: 
星期五, 一月 13, 2023
AI, IOT, Growth, WIHN, WKEY, Semiconductor, Divestment

WISeKey Announces FY 2022 Preliminary Revenues of $25.6 Million, a 15% Increase from FY 2021, Despite the Divestiture of arago

Key Points: 
  • WISeKey Announces FY 2022 Preliminary Revenues of $25.6 Million, a 15% Increase from FY 2021, Despite the Divestiture of arago
    Semiconductor FY 2022 revenues increased to $23.2 million, or 38% as compared to FY 2021
    Geneva, Switzerland, January 13, 2023 – Ad-Hoc announcement pursuant to Art.
  • 53 of SIX Listing Rules– WISeKey International Holding Ltd (NASDAQ: WKEY / SIX: WIHN) (“WISeKey” or the “Company”), a leading Swiss cybersecurity, AI and IoT company announced today its preliminary unaudited revenues for the year ended December 31, 2022.
  • Consolidated revenues for FY 2022 were $25.6 million, increasing by 15% as compared to $22.3 million reported for FY 2021.
  • The increase was achieved despite the divestiture of arago and it was mainly due to higher revenues from our semiconductors segment, which reported revenues of $23.2 million for the year.